Sterile Manufacturing Process for Oncology Injectables
Oncology drugs are highly potent and cytotoxic in nature.
These require stringent quality controls and regulatory adherence.
Chemotherapy is usually given in the form of injectables or infusions.
What are sterile injectables?
Sterile injectables are drugs administered by injection.
They are sterile preparations, free from pyrogen or any other microorganism.
It includes –
- Intravenous injections
- IV infusions
- Intramuscular injection
- Subcutaneous injection
The need for sterility in Injectables-
The drugs are directly administered into the bloodstream.
They have rapid effects. These bypass the first-pass metabolism.
Any contamination may directly lead to severe health risks.
What are the benefits of injectables?
- These bypass the GIT.
- 100 percent bioavailability
- Rapid action
- No GIT side effects
What is the sterile manufacturing process for oncology injectables?
- Aseptic manufacturing –
The drugs are mixed or processed in sterile closed-loop conditions.
- Sterile raw material
- Pyrogen-free water
- Environmental controls
- Containment control
Personnel safety –
The working people must be protected from cytotoxic agents.
- Use protective gear and clothing.
- Air lock-lock systems
- Access restrictions
- Sterilization and filtration –
The products are filtered to remove particulate matter.
The glass vials are washed and depyrogenated.
Rubber stoppers are sterilized.
- Aseptic fill finish /lyophilisation-
The sterile liquid preparations are dispensed in sterile vials or containers in an aseptic chamber.
The injectable flow is unidirectional.
The filling process should be free from any contamination.
The heat-sensitive oncology drugs are half-stoppered in the vials.
These are transferred to freeze–dryers to remove water.
The aluminum seals are crimped onto the vials immediately removing from the freeze dryers.
The sealing must be done in protected air zones to prevent contamination.
- Quality control and inspection –
The vials are inspected for leaks or particulate matter.
Container closure integrity.
Sterility testing/bacterial endotoxin testing.
WHO – GMP Regulations for sterile injectable manufacturing
The GMP standards emphasized:
- Product quality
- Sterility control
- Manufacturing consistency
- Regulatory compliance
EU-GMP regulations for sterile injectable manufacturing
EU-GMP practices emphasize-
- Cleanroom classification
- Personnel controls
- Contamination prevention
- Environment monitoring
- Air barriers
Why choose Aprazer Healthcare for oncology injectables?
Aprazer Healthcare is the leading oncology injectable manufacturer.
We are global oncology drug exporters.
We are equipped with world-class infrastructure.
We are accepted and trusted due to our quality attributes-
- Global Manufacturing standards
- Rigorous quality controls
- Regulatory compliance
- Containment prevention
- Cost-efficient manufacturing
Reference Link
https://www.who.int/teams/health-product-and-policy-standards/standards-and-specifications/norms-and-standards-for-pharmaceuticals/guidelines/productionhttps://www.ema.europa.eu/en/human-regulatory-overview/research-development/compliance-research-development/good-manufacturing-practice
